FGY 1153

Drug Profile

FGY 1153

Alternative Names: FGY-1153

Latest Information Update: 10 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Gedeon Richter
  • Class Analgesics; Eye disorder therapies
  • Mechanism of Action Bradykinin B1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Retinal disorders

Most Recent Events

  • 26 Aug 2017 Preclinical trials in Retinal disorders in Hungary
  • 26 Aug 2017 Pharmacodynamics data from a preclinical trial in Retinal disorders presented at the Annual Congress of the European Society of Cardiology (ESC-2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top